Alto Neuroscience, Inc. (ANRO)

24.03 +0.51 (+2.17%) USD  |  NYSE  |  Oct 08, 16:00
24.02 -0.01 (-0.04%) Pre-Market: 20:00
More

Alto Neuroscience EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ANRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to . Start Trial.
Date Value

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade